{
  "url": "https://www.morningstar.com/news/dow-jones/202508241398/terumo-to-buy-uk-based-organox-for-15-billion",
  "authorsByline": "",
  "articleId": "b3f8cc10cb6f455ab025fe9c555f4df1",
  "source": {
    "domain": "morningstar.com",
    "location": {
      "country": "us",
      "state": "IL",
      "county": "Cook County",
      "city": "Chicago",
      "coordinates": {
        "lat": 41.8755616,
        "lon": -87.6244212
      }
    }
  },
  "imageUrl": "https://images.contentstack.io/v3/assets/blt4eb669caa7dc65b2/blta7dd42ebdd7b93b8/61899b34a3c7df383578294c/morningstar-og.png",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-24T20:41:00-05:00",
  "addDate": "2025-08-25T01:55:15.138911+00:00",
  "refreshDate": "2025-08-25T01:55:15.138912+00:00",
  "score": 1.0,
  "title": "Terumo to Buy U.K.-Based OrganOx for $1.5 Billion",
  "description": "",
  "content": "Terumo plans to acquire OrganOx, a U.K. maker of organ preservation devices, for $1.5 billion, marking its strategic entry into the organ-transplantation field.\n\nThe Japanese medical-equipment maker said Monday that it would acquire all shares of the U.K. company it didn't already own. It currently holds 0.5% voting right in OrganOx, founded in 2008 as a spinoff from the University of Oxford.\n\nTerumo said it would buy OrganOx shares from London-based venture capital firm BGF and Paris-based investment company Lauxera Capital Partners.\n\n\"Donated organs are an extremely precious medical resource, and OrganOx's mission to deliver transplantable organs in optimal condition deeply resonates with our unwavering commitment to patients,\" Terumo Chief Executive Hikaru Samejima said.\n\nThe Japanese company said the acquisition was expected to be completed once it obtains necessary regulatory approvals and permits.",
  "medium": "Article",
  "links": [],
  "labels": [],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "OrganOx shares",
      "weight": 0.1273555
    },
    {
      "name": "U.K.-Based OrganOx",
      "weight": 0.1132967
    },
    {
      "name": "OrganOx",
      "weight": 0.11253389
    },
    {
      "name": "organ preservation devices",
      "weight": 0.11228521
    },
    {
      "name": "transplantable organs",
      "weight": 0.110358536
    },
    {
      "name": "Donated organs",
      "weight": 0.11025439
    },
    {
      "name": "Terumo Chief Executive Hikaru Samejima",
      "weight": 0.10247099
    },
    {
      "name": "necessary regulatory approvals",
      "weight": 0.087744646
    },
    {
      "name": "Terumo",
      "weight": 0.084471904
    },
    {
      "name": "Lauxera Capital Partners",
      "weight": 0.08409166
    }
  ],
  "topics": [],
  "categories": [
    {
      "name": "Business"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Company News",
      "score": 0.94140625
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.57763671875
    },
    {
      "name": "/News/Health News",
      "score": 0.31005859375
    }
  ],
  "sentiment": {
    "positive": 0.6295557,
    "negative": 0.024126133,
    "neutral": 0.34631822
  },
  "summary": "Japanese medical-equipment maker, Terumo, plans to acquire OrganOx, a U.K. company that produces organ preservation devices. The acquisition will mark Terumo's entry into the organ-transplantation field. The company currently holds a 0.5% voting power in OrganOx. The purchase will be made through London-based venture capital firm BGF and Paris-based investment company Lauxera.",
  "shortSummary": "Terumo plans to acquire UK-based Organox for $1.5 billion to enter into the organ-transplantation market, acquiring all shares it owns.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "703d3fd426684e4eac63d46105838dd4",
  "places": [],
  "scraped_sources": [],
  "argos_summary": "Terumo plans to acquire OrganOx, a U.K. maker of organ preservation devices, for $1.5 billion, marking its strategic entry into the organ-transplantation field.\n\nThe Japanese medical-equipment maker said Monday that it would acquire all shares of the U.K. company it didn't already own. It currently holds 0.5% voting right in OrganOx, founded in 2008 as a spinoff from the University of Oxford.\n\nTerumo said it would buy OrganOx shares from London-based venture capital firm BGF and Paris-based inve...",
  "argos_id": "F0PXPUFBG"
}